Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
AIMCompany Name
AIM IMMUNOTECH INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTAIM IMMUNOTECH INC - Return on Invested Capital Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
AIM - ROIC Historical data
| Date | Invested Capital | Net Income Common Stock | Return on Invested Capital |
|---|---|---|---|
| 6/30/2025 | $ -3.74M | $ -16.17M | 0% |
| 3/31/2025 | $ -1.33M | $ -15.21M | 0% |
| 12/31/2024 | $ 1.62M | $ -17.32M | -1069.8% |
| 9/30/2024 | $ 6.31M | $ -23.93M | -379.04% |
| 6/30/2024 | $ 9.46M | $ -28.05M | -296.43% |
| 3/31/2024 | $ 8.18M | $ -31.12M | -380.6% |
| 12/31/2023 | $ 10.95M | $ -28.96M | -264.44% |
| 9/30/2023 | $ 23.35M | $ -20.77M | -88.96% |
| 6/30/2023 | $ 30.94M | $ -19.34M | -62.53% |
| 3/31/2023 | $ 35.8M | $ -19.29M | -53.87% |
Key Performance Insights, Last 5 Years
- AIM IMMUNOTECH INC's latest trailing twelve months (TTM) ROIC stands at -18.39%.
- Over the past 5 years, AIM IMMUNOTECH INC's average ROIC has been -161.85%.
- The median ROIC for AIM IMMUNOTECH INC during this period was -48.73%
- AIM IMMUNOTECH INC reached its highest ROIC over the past 5 years at -18.39%.
- The lowest ROIC recorded by AIM IMMUNOTECH INC in the same timeframe -1069.8%
AIM IMMUNOTECH INC's ROIC vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROIC Benchmarks
Similar metrics to ROIC:
- Cash Return on Invested Capital - [Calculation] Cash Return on Invested Capital (CROIC) measures how well a company uses its invested capital to produce cash. It is calculated as Free Cash Flow [FCF] divided by invested capital [InvCapital].
- Invested Capital - [Calculation] Invested Capital is the total amount of money raised by a business in the form [Equity] and/or [Debt].
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
Definition of Return on Invested Capital
[Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].Net Inc. Cmn. / Inv. Capital
(=) ROIC ROIC for AIM IMMUNOTECH INC is calculated as follows: Net Inc. Cmn. [ $ -11.67M ] / Inv. Capital [ $ 63.46M ]
(=) ROIC [ -18.39% ] AIM - Return on Invested Capital, Last 5 years
-1069.8%
Minimum
Dec 31, 2024
-18.39%
Maximum
Sep 30, 2020
-161.85%
Average
-48.73%
Median
ROIC Benchmark AnalysisMarket
The chart above depicts the distribution of ROIC for companies in the Total Stock Market. The average ROIC of the companies is 0.68% with a standard deviation of 15.2%.
The following table provides additional summary stats:
ROIC in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | -46.36% |
| max | 48.66% |
| average | 0.68% |
| median | 3.38% |
| std | 15.2% |